About: TCS-OX2-29

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

TCS-OX2-29 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50 of 40nM and selectivity of around 250x for OX2 over OX1 receptors. Orexin antagonists are expected to be useful for the treatment of insomnia, with subtype-selective antagonists such as TCS-OX2-29 potentially offering more specificity of action compared to non-selective orexin antagonists like almorexant.

thumbnail
Property Value
dbo:abstract
  • TCS-OX2-29 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50 of 40nM and selectivity of around 250x for OX2 over OX1 receptors. Orexin antagonists are expected to be useful for the treatment of insomnia, with subtype-selective antagonists such as TCS-OX2-29 potentially offering more specificity of action compared to non-selective orexin antagonists like almorexant. (en)
dbo:casNumber
  • 372523-75-6
dbo:pubchem
  • 10408514
dbo:thumbnail
dbo:wikiPageID
  • 22229405 (xsd:integer)
dbo:wikiPageLength
  • 2259 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1120556595 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 23 (xsd:integer)
dbp:casNumber
  • 372523 (xsd:integer)
dbp:h
  • 31 (xsd:integer)
dbp:iupacName
  • -1 (xsd:integer)
dbp:iupharLigand
  • 4038 (xsd:integer)
dbp:n
  • 3 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 10408514 (xsd:integer)
dbp:smiles
  • c3cnccc3CNCCNCCc2cc1OC (en)
dbp:verifiedrevid
  • 398756641 (xsd:integer)
dbp:width
  • 240 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • TCS-OX2-29 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50 of 40nM and selectivity of around 250x for OX2 over OX1 receptors. Orexin antagonists are expected to be useful for the treatment of insomnia, with subtype-selective antagonists such as TCS-OX2-29 potentially offering more specificity of action compared to non-selective orexin antagonists like almorexant. (en)
rdfs:label
  • TCS-OX2-29 (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License